Lahdensuo et al. presented a hazard ratio for risk of death by prostate cancer of 2.156 (95% CI 1.169–3.976, p = 0.014) in a univariate analysis that compared those with a total loss of PTEN to those with partial or no loss of PTEN (48). This evidence concerns the gene PTEN and prostate carcinoma.